The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...

Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic sinus infection, the drugmakers ...

Chances are, you may know a family living with food allergies. Food allergies are more prevalent than many realize, ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the ...

The president’s call for removal of the metal from childhood inoculations set off alarms. About half of shots for polio, ...

Potentially half of all those using weight loss jabs in this country are doing just that – by buying on the black market. My ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

October 2025 Tezspire approved in the US for chronic rhinosinusitis with nasal polyps Approval broadens indication for Tezspire to a second disease characterised by epithelial-driven inflammationAstra ...

Harrow is a small biotech company focused on acquiring and commercializing ophthalmic pharmaceutical products in the US.

YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and ...

South Korean pharmaceutical company Celltrion announced on the 15th that it has received marketing authorization from New ...